Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Mersana Therapeutics Inc. logo

Mersana Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 184 M  90-day average vol: 2,236,833

Previous close: 1.65  Open: 1.69  Bid: 1.84  Ask: 1.9
52 week range    
Last updated: Monday 4th December 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


MRSN Income Statement

Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends39 M64 M28 M88 M170 M204 M
Basic EPS from continuing operations-0.65-1.43-2.41
Basic EPS total-0.65-1.43-2.41-2.18
Basic weighted shares outstanding12 M23 M43 M61 M71 M94 M
Depreciation-928000.0-1 M1 M1 M900000.0-900000.0
DepreciationAndAmortization-928000.0-1 M1 M1 M900000.0-900000.0
Diluted EPS total-3.22-2.79-0.65-1.43-2.41-2.18
Diluted normalized net income/share-2.41
Diluted weighted shares outstanding12 M23 M43 M61 M71 M94 M
GeneralAndAdministrativeExpense10 M16 M17 M22 M37 M57 M
Gross operating profit18 M11 M42 M828000.043000.027 M
Income before tax-39 M-64 M-28 M-88 M-170 M-204 M
Interest income910000.01 M2 M424000.065000.03 M
InterestExpenseNonOperating234000.0359000.01 M3 M
MiscOtherSpecialCharges9 M42 M828000.043000.0
Net income from total operations-39 M-64 M-28 M-88 M-170 M-204 M
NetIncomeCommonStockholders-39 M-129 M-28 M-88 M-170 M-408 M
NetIncomeContinuousOperations-39 M-64 M-28 M-88 M-170 M-204 M
NetNonOperatingInterestIncomeExpense910000.01 M2 M65000.0-1 M-445000.0
Normalized income-134 M
Operating income-40 M-66 M-30 M-88 M-169 M-204 M
Operating income before depreciation (EBITDA)-38 M-63 M-27 M-87 M-168 M-201 M
OperatingExpense-57 M-76 M72 M89 M169 M-230 M
Other income net-9 M-42 M-828000.0-43000.0
OtherGandA10 M16 M17 M22 M37 M57 M
OtherOperatingExpenses-57 M-76 M72 M3 M4 M-4 M
OtherunderPreferredStockDividend39 M64 M28 M88 M170 M204 M
PreferredStockDividends39 M64 M28 M88 M170 M204 M
RentAndLandingFees10 M16 M57 M
Research & development expense47 M60 M55 M67 M132 M173 M
ResearchExpense47 M60 M55 M67 M132 M173 M
SalariesAndWages-1 M-4 M-22 M
Selling Gen & administrative expense10 M16 M17 M22 M37 M57 M
Total Income available for interest expense (EBIT)-39 M-64 M-28 M-88 M-169 M-201 M
Total common shares outstanding23 M48 M45 M69 M83 M108 M
Total net income-39 M-64 M-28 M-88 M-170 M-204 M
Total ordinary shares121 M121 M121 M121 M121 M121 M
Total revenues18 M11 M42 M828000.043000.027 M
TotalExpenses-57 M-76 M72 M89 M169 M-230 M
TotalRevenue18 M11 M42 M828000.043000.027 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today